NO20044322L - Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament - Google Patents

Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament

Info

Publication number: NO20044322L
Authority: NO; Norway
Prior art keywords: benzoxanone; drug; preparation; derived compounds; derived
Prior art date: 2002-04-09

Application number

NO20044322A

Other languages

English (en)

Norwegian (no)

Inventor

Antoni Torrens Jover

Jose Aurelio Castrillo Perez

Jordi Frigola Constansa

Josep Mas Prio

Alberto Dordal Zueras

Maria Angeles Fisas Escasany

Original Assignee

Esteve Labor Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-09

Filing date

2004-10-12

Publication date

2004-10-12

2004-10-12 Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr

2004-10-12 Publication of NO20044322L publication Critical patent/NO20044322L/no

Links

VMUXSMXIQBNMGZ-UHFFFAOYSA-N 3,4-dihydrocoumarin Chemical compound C1=CC=C2OC(=O)CCC2=C1 VMUXSMXIQBNMGZ-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO20044322A 2002-04-09 2004-10-12 Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament NO20044322L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200200813A ES2193875B2 (es)	2002-04-09	2002-04-09	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
PCT/EP2003/003629 WO2003084952A1 (en)	2002-04-09	2003-04-08	Benzoxazinone-derived compounds, their preparation und use as medicaments

Publications (1)

Publication Number	Publication Date
NO20044322L true NO20044322L (no)	2004-10-12

Family

ID=28686085

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044322A NO20044322L (no)	2002-04-09	2004-10-12	Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament

Country Status (28)

Country	Link
US (3)	US7056914B2 (de)
EP (2)	EP1497285B1 (de)
JP (1)	JP2005529866A (de)
KR (1)	KR20050008679A (de)
CN (1)	CN1659164A (de)
AR (2)	AR039256A1 (de)
AT (2)	ATE489382T1 (de)
AU (2)	AU2003222804A1 (de)
BR (1)	BR0309083A (de)
CA (1)	CA2481701A1 (de)
DE (2)	DE60335094D1 (de)
DK (1)	DK1500654T3 (de)
EC (1)	ECSP045353A (de)
ES (3)	ES2193875B2 (de)
HR (1)	HRP20040919A2 (de)
IL (1)	IL164442A0 (de)
IS (1)	IS7491A (de)
MA (1)	MA27692A1 (de)
MX (1)	MXPA04009889A (de)
NO (1)	NO20044322L (de)
NZ (1)	NZ536167A (de)
PL (1)	PL372537A1 (de)
PT (1)	PT1500654E (de)
RU (1)	RU2004133041A (de)
TN (1)	TNSN04203A1 (de)
UA (1)	UA79460C2 (de)
WO (2)	WO2003084952A1 (de)
ZA (1)	ZA200408275B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ES2228268B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2228267B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2222833B1 (es) *	2003-07-30	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	Compuestos piperidinicos 1,4-disustituidos, su preparacion y su uso como medicamentos.
WO2005090340A1 (ja) *	2004-03-22	2005-09-29	Banyu Pharmaceutical Co., Ltd.	ピペリジン－１－カルボキサミド誘導体
US8147853B2 (en)	2005-02-15	2012-04-03	The Procter & Gamble Company	Personal care compositions containing hydrophobically modified non-platelet particles
WO2006102113A2 (en) *	2005-03-21	2006-09-28	The Procter & Gamble Company	Multi-phase personal care composition comprising visually distinct phases
EP1874409A1 (de) *	2005-04-13	2008-01-09	The Procter and Gamble Company	Strukturierte, mehrphasige körperpflegezusammensetzung mit verzweigten anionischen tensiden
US7820609B2 (en)	2005-04-13	2010-10-26	The Procter & Gamble Company	Mild, structured, multi-phase personal cleansing compositions comprising density modifiers
ITMI20050909A1 (it) *	2005-05-19	2006-11-20	Acraf	Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
US20120015009A9 (en) *	2005-06-07	2012-01-19	The Procter & Gamble Company	Multi-phased personal care composition comprising a blooming perfume composition
ITMI20051523A1 (it) *	2005-08-03	2007-02-04	Acraf	Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP1957374A2 (de) *	2005-12-08	2008-08-20	The Procter and Gamble Company	Ein nahe einer flächentopographie positioniertes etikett in der form umfassender behälter
JP4086895B2 (ja) *	2005-12-28	2008-05-14	日本たばこ産業株式会社	３，４−ジヒドロベンゾオキサジン化合物及びバニロイド受容体１型（ｖｒ１）活性阻害剤
US20070167338A1 (en) *	2006-01-09	2007-07-19	Mchugh Colin M	Multiphase personal care compositions comprising beads
US8104616B2 (en)	2006-02-11	2012-01-31	The Procter & Gamble Company	Clamshell package for holding and displaying consumer products
US8153144B2 (en) *	2006-02-28	2012-04-10	The Proctor & Gamble Company	Stable multiphase composition comprising alkylamphoacetate
WO2008020455A2 (en) *	2006-08-14	2008-02-21	Council Of Scientific & Industrial Research	Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
EP1902733A1 (de) *	2006-09-19	2008-03-26	Laboratorios Del Dr. Esteve, S.A.	Kombination von einem NMDA Rezeptorligand und einer Verbindung mit 5-HT6 Rezeptor-Affinität
CL2007003044A1 (es) *	2006-10-24	2008-07-04	Wyeth Corp	Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
US20090029900A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with distinct fragrance characters
US20090028809A1 (en) *	2007-07-27	2009-01-29	Jonathan Robert Cetti	Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials
US20090028808A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with variable concentrations of partitioned benefit or suspended benefit agents
US7733945B2 (en) *	2008-03-18	2010-06-08	On-Ramp Wireless, Inc.	Spread spectrum with doppler optimization
US20090275574A1 (en) *	2008-05-05	2009-11-05	Astrazeneca Ab	Novel compounds-300
JP5642661B2 (ja) *	2009-03-05	2014-12-17	塩野義製薬株式会社	Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
CN110684043B (zh) *	2019-08-13	2022-09-06	温州大学	一种c-n轴手性芳胺化合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU691829B2 (en) *	1993-07-16	1998-05-28	Merck & Co., Inc.	Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
AU688498B2 (en)	1994-04-14	1998-03-12	Merck & Co., Inc.	Alpha1c adrenergic receptor antagonists
AU7692996A (en)	1995-12-01	1997-06-27	Ciba-Geigy Ag	Receptor antagonists
AU1328197A (en)	1995-12-01	1997-06-19	Synaptic Pharmaceutical Corporation	Aryl sulfonamide and sulfamide derivatives and uses thereof
AU1698997A (en)	1996-01-16	1997-08-11	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
EP0944388A4 (de)	1996-04-03	2001-08-16	Merck & Co Inc	Hemmern von farnesyl protein transferase
US6043246A (en)	1996-12-03	2000-03-28	Banyu Pharmaceutical Co., Ltd.	Urea derivatives
WO1998035957A1 (en)	1997-02-14	1998-08-20	Bayer Corporation	Amide derivatives as selective neuropeptide y receptor antagonists
AU6309698A (en)	1997-03-12	1998-09-29	Banyu Pharmaceutical Co., Ltd.	Drugs containing aminopyridine derivatives as the active ingredient
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
NZ510988A (en)	1998-10-07	2005-01-28	Ortho Mcneil Pharm Inc	N-aralkylaminotetralins useful as ligands for the neuropeptide Y5 receptor
WO2001007409A1 (en)	1999-07-23	2001-02-01	Astrazeneca Uk Limited	Carbazole derivatives and their use as neuropeptide y5 receptor ligands
WO2001013917A1 (en)	1999-08-26	2001-03-01	Bristol-Myers Squibb Company	Npy antagonists: spiroisoquinolinone derivatives
SE9904652D0 (sv) *	1999-12-17	1999-12-17	Astra Pharma Prod	Novel Compounds
AU2001246494A1 (en)	2000-03-03	2001-09-12	Novartis Ag	Condensed thiazolamines and their use as neuropeptide y5 antagonists
WO2002094825A1 (en)	2001-05-22	2002-11-28	Banyu Pharmaceutical Co., Ltd.	Novel spiropiperidine derivative
ATE427935T1 (de) *	2001-08-07	2009-04-15	Banyu Pharma Co Ltd	Spiro isobenzofurane als neuropeptid y rezeptor antagonisten
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.

2002
- 2002-04-09 ES ES200200813A patent/ES2193875B2/es not_active Expired - Fee Related
2003
- 2003-04-04 US US10/407,343 patent/US7056914B2/en not_active Expired - Fee Related
- 2003-04-04 AR ARP030101184A patent/AR039256A1/es not_active Application Discontinuation
- 2003-04-08 WO PCT/EP2003/003629 patent/WO2003084952A1/en not_active Ceased
- 2003-04-08 AT AT03718741T patent/ATE489382T1/de not_active IP Right Cessation
- 2003-04-08 MX MXPA04009889A patent/MXPA04009889A/es active IP Right Grant
- 2003-04-08 ES ES03718741T patent/ES2356815T3/es not_active Expired - Lifetime
- 2003-04-08 AR ARP030101235A patent/AR048567A1/es not_active Application Discontinuation
- 2003-04-08 EP EP03718741A patent/EP1497285B1/de not_active Expired - Lifetime
- 2003-04-08 DE DE60335094T patent/DE60335094D1/de not_active Expired - Lifetime
- 2003-04-08 US US10/409,235 patent/US7041665B2/en not_active Expired - Fee Related
- 2003-04-08 JP JP2003582149A patent/JP2005529866A/ja active Pending
- 2003-04-08 PL PL03372537A patent/PL372537A1/xx not_active Application Discontinuation
- 2003-04-08 KR KR10-2004-7016130A patent/KR20050008679A/ko not_active Withdrawn
- 2003-04-08 IL IL16444203A patent/IL164442A0/xx unknown
- 2003-04-08 CN CN038128853A patent/CN1659164A/zh active Pending
- 2003-04-08 HR HR20040919A patent/HRP20040919A2/hr not_active Application Discontinuation
- 2003-04-08 CA CA002481701A patent/CA2481701A1/en not_active Abandoned
- 2003-04-08 RU RU2004133041/04A patent/RU2004133041A/ru not_active Application Discontinuation
- 2003-04-08 NZ NZ536167A patent/NZ536167A/en unknown
- 2003-04-08 AU AU2003222804A patent/AU2003222804A1/en not_active Abandoned
- 2003-04-08 BR BR0309083-3A patent/BR0309083A/pt not_active IP Right Cessation
- 2003-04-09 DE DE60303440T patent/DE60303440T2/de not_active Expired - Lifetime
- 2003-04-09 EP EP03712152A patent/EP1500654B1/de not_active Expired - Lifetime
- 2003-04-09 PT PT03712152T patent/PT1500654E/pt unknown
- 2003-04-09 AT AT03712152T patent/ATE316966T1/de not_active IP Right Cessation
- 2003-04-09 WO PCT/ES2003/000162 patent/WO2003084939A1/es not_active Ceased
- 2003-04-09 AU AU2003216934A patent/AU2003216934A1/en not_active Abandoned
- 2003-04-09 ES ES03712152T patent/ES2258219T3/es not_active Expired - Lifetime
- 2003-04-09 DK DK03712152T patent/DK1500654T3/da active
- 2003-08-04 UA UA20041109155A patent/UA79460C2/uk unknown
2004
- 2004-10-06 IS IS7491A patent/IS7491A/is unknown
- 2004-10-08 MA MA27902A patent/MA27692A1/fr unknown
- 2004-10-08 TN TNP2004000203A patent/TNSN04203A1/en unknown
- 2004-10-08 EC EC2004005353A patent/ECSP045353A/es unknown
- 2004-10-12 NO NO20044322A patent/NO20044322L/no not_active Application Discontinuation
- 2004-10-13 ZA ZA200408275A patent/ZA200408275B/en unknown
2006
- 2006-01-24 US US11/338,363 patent/US7514429B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003216934A1 (en)	2003-10-20
DE60303440D1 (de)	2006-04-13
MA27692A1 (fr)	2006-01-02
US7056914B2 (en)	2006-06-06
KR20050008679A (ko)	2005-01-21
US7041665B2 (en)	2006-05-09
ZA200408275B (en)	2006-04-26
ATE316966T1 (de)	2006-02-15
PL372537A1 (en)	2005-07-25
ATE489382T1 (de)	2010-12-15
TNSN04203A1 (en)	2007-03-12
EP1500654A1 (de)	2005-01-26
IL164442A0 (en)	2005-12-18
EP1497285B1 (de)	2010-11-24
ES2258219T3 (es)	2006-08-16
DK1500654T3 (da)	2006-06-06
HRP20040919A2 (en)	2005-04-30
DE60335094D1 (de)	2011-01-05
EP1500654B1 (de)	2006-02-01
DE60303440T2 (de)	2006-10-26
WO2003084952A1 (en)	2003-10-16
AR048567A1 (es)	2006-05-10
US7514429B2 (en)	2009-04-07
EP1497285A1 (de)	2005-01-19
ECSP045353A (es)	2005-01-28
CN1659164A (zh)	2005-08-24
BR0309083A (pt)	2005-04-19
ES2356815T3 (es)	2011-04-13
HK1069820A1 (en)	2005-06-03
NZ536167A (en)	2006-06-30
RU2004133041A (ru)	2005-09-10
US20040067941A1 (en)	2004-04-08
US20060128701A1 (en)	2006-06-15
IS7491A (is)	2004-10-06
PT1500654E (pt)	2006-06-30
MXPA04009889A (es)	2005-08-16
ES2193875B2 (es)	2005-03-01
AR039256A1 (es)	2005-02-16
AU2003222804A1 (en)	2003-10-20
US20040058920A1 (en)	2004-03-25
CA2481701A1 (en)	2003-10-16
WO2003084939A1 (es)	2003-10-16
JP2005529866A (ja)	2005-10-06
UA79460C2 (en)	2007-06-25
ES2193875A1 (es)	2003-11-01

Legal Events

Date	Code	Title	Description
2008-11-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1532149T3 (da)	2010-05-10	8-[3-amino-piperiden-1-yl]-xanthiner, fremstilling deraf og anvendelse deraf som lægemiddel
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
DK2298769T3 (da)	2014-01-20	Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
DK1562946T3 (da)	2010-09-20	Nye xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
NO20025879L (no)	2003-01-29	Acylfenylureaderivater, fremgangsmåter for fremstilling derav og deres anvendelse som legemiddel
NO20040680D0 (no)	2004-02-16	Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20054220D0 (no)	2005-09-12	Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1480955T3 (da)	2007-10-29	O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK1445252T3 (da)	2006-06-19	Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
DK1592457T3 (da)	2012-10-22	Folat-vinblastin-konjugat som lægemiddel
DK1218341T3 (da)	2005-12-12	Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1500654T3 (da)	2006-06-06	Benzoxazinonderivater, fremstilling deraf og anvendelse deraf som lægemidler
NO20025357L (no)	2002-11-08	Antranylamider og deres anvendelse som legemidler
DK1670458T3 (da)	2007-04-23	1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
DK1381605T3 (da)	2005-05-09	Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20054876D0 (no)	2005-10-21	Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1513835T3 (da)	2006-12-27	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1453810T3 (da)	2009-07-20	Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme
NO20043349L (no)	2004-10-05	Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1556377T3 (da)	2006-10-23	Cyclopropylthienylcarboxamider som fungicider
DK1525193T3 (da)	2008-04-28	Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
DK1523473T3 (da)	2013-06-03	Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel.